Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898531-16-000615
Filing Date
2016-02-08
Accepted
2016-02-08 09:52:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP egvf_ebi-13g.htm SC 13G 68280
  Complete submission text file 0000898531-16-000615.txt   69768
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Subject) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: SC 13G | Act: 34 | File No.: 005-32878 | Film No.: 161394300
SIC: 8071 Services-Medical Laboratories

Mailing Address 89 SUMMIT AVENUE 3RD FLOOR SUMMIT NJ 07901
Business Address 89 SUMMIT AVENUE 3RD FLOOR SUMMIT NJ 07901 908-378-2882
Evermore Global Advisors, LLC (Filed by) CIK: 0001479983 (see all company filings)

EIN.: 270406745 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G